Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway.

@article{Xu2017OxytocinIR,
  title={Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway.},
  author={Huan Xu and Shi Fu and Yanbo Chen and Qi Zhi Chen and Meng Gu and Chong Liu and Zhiguang Qiao and Juan Zhou and Zhong Wang},
  journal={Clinical science},
  year={2017},
  volume={131 7},
  pages={595-607}
}
The aim of the present study was to evaluate oxytocin and benign prostatic hyperplasia (BPH), and study the cell signalling mechanism. Investigation was performed in patients about the correlation between oxytocin level and BPH. Mice were injected with oxytocin or oxytocin antagonist for 2 weeks and the prostate morphology was studied after their sacrifice… CONTINUE READING